Composition of sodium fusidafe as injection and preparing method thereof

A technology of sodium fusidate and a composition, applied in the field of pharmaceutical preparations, can solve the problems of high cost, high amount of buffer salt, irritation at the venipuncture site, pain, etc., and achieves improved tolerance, simple process and reduced production cost Effect

Active Publication Date: 2006-08-16
SHANDONG BESTCOMM PHARMA CO LTD
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Two different production lines are required for production, and the cost is high
The high amount of buffer salt in the special solvent may cause irritation and pain at the venipuncture site in clinical application, and sometimes cause phlebitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Take 4 / 5 of the prescribed amount of water for injection, add the prescribed amount of disodium edetate, and stir to dissolve. Add the prescribed amount of mannitol, disodium hydrogen phosphate and citric acid, stir to dissolve completely, let cool to room temperature, add the prescribed amount of sodium fusidate, stir to dissolve, add water for injection to the full amount. Add special activated carbon for injection to the liquid medicine, stir for 30 minutes, decarbonize and filter. 0.22μm microporous membrane filter to sterilize. Filling liquid medicine, half plug. Freeze-dried, cork and cap.

[0020] The final dosage of buffering agent and metal ion complexing agent is selected according to the results of dissolution, reconstitution and compatibility. The research results are shown in Table 1

[0021] prescription

Embodiment 2

[0023] Sodium fusidate for injection prepared according to prescription 6 was placed under high temperature (60°C), high temperature (40°C) and light (4500lx) conditions for 10 days respectively, and samples were taken at 5 and 10 days respectively to check the quality The index results are shown in Table 2.

[0024] The results showed that sodium fusidate for injection was placed in high temperature (60°C), light (4500lx), and high temperature (40°C) environment for 10 days, and all quality indicators were checked, compared with 0 days, except for high temperature (60°C). The substance increases, the content decreases, and the color changes; except that the light (4500lx) related substances increase slightly, other indicators have no obvious changes.

[0025]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A freeze-dried powder injection of sodium fusidate composition for treating the serious Staphylococcus infection contains sodium fusidate, bisodium hydrogen phosphate and citric acid in weight ratio of 500: (78-113): (4-5.7). The water for injection is used as its solvent.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to a freeze-dried preparation containing sodium fusidate for treating various severe staphylococcal infections and a preparation method thereof. Background technique [0002] Fusidic acid (Fusidic Acid, also known as brown mycin), belongs to fusidic acid antibiotics. It was first extracted from Fusidium coccineum fungus in 1962 by the Danish Leo Pharmaceutical Company. The antibacterial mechanism is to interfere with the elongation factor G by inhibiting the translocation of ribosomes, thereby hindering the synthesis of bacterial proteins. This unique mechanism of action avoids cross-resistance with other antibacterial drugs. Although it has been widely used abroad for more than 30 years (the domestic clinical application is less), it still maintains strong antibacterial activity and low drug resistance rate against most Staphylococcus strains, which has attr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/19A61K47/16A61K47/06A61P31/04
Inventor 孟凡清牛传芹刘理南
Owner SHANDONG BESTCOMM PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap